Učitavanje...
Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension?
In April 2008, a panel was convened to discuss the effects of angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers in the treatment of hypertension and the possible added benefit of using these agents together. The panel was moderated by Marvin Moser, MD, Clinical Professor...
Spremljeno u:
| Izdano u: | J Clin Hypertens (Greenwich) |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Blackwell Publishing Inc
2008
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109894/ https://ncbi.nlm.nih.gov/pubmed/18550939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2008.08560.x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|